Selenium protection from DNA damage and regulation of apoptosis signaling following cyclophosphamide induced cardiotoxicity in rats

References

• Adamcová M, Gersl V, Hrdina R, Melka M, Mazurová Y, Vávrová J, Palicka V, Kokstein Z. 1999. Cardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbits. J Cancer Res Clin Oncol. 125:268–274. doi: 10.1007/s004320050273.
   PubMed Web of Science ®Google Scholar
• Ahsan U, Kamran Z, Raza I, Ahmad S, Babar W, Riaz M, Iqbal Z. 2014. Role of selenium in male reproduction—a review. Anim Reprod Sci. 146:55–62. doi: 10.1016/j.anireprosci.2014.01.009.
   PubMed Web of Science ®Google Scholar
• Allred D, Harvey JM, Berardo M, Clark GM. 1998. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 11:155–168.
   PubMed Web of Science ®Google Scholar
• Appelbaum F, Strauchen J, Graw R Jr, Savage D, Kent K, Ferrans V, Herzig G. 1976. Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity. Lancet. 307:58–62. doi: 10.1016/S0140-6736(76)90151-3.
   Google Scholar
• Asiri YA. 2010. Probucol attenuates cyclophosphamide-induced oxidative apoptosis, p53 and Bax signal expression in rat cardiac tissues. Oxid Med Cell Longev. 3:308–316. doi: 10.4161/oxim.3.5.13107.
   PubMed Web of Science ®Google Scholar
• Avci H, Epikmen ET, İ̇pek E, Tunca R, Birincioglu S, Akşit H, Sekkin S, Akkoç AN, Boyacioglu M. 2017. Protective effects of silymarin and curcumin on cyclophosphamide-induced cardiotoxicity. Exp Toxicol Pathol. 69:317–327. doi: 10.1016/j.etp.2017.02.002.
   PubMedGoogle Scholar
• Benstoem C, Goetzenich A, Kraemer S, Borosch S, Manzanares W, Hardy G, Stoppe C. 2015. Selenium and its supplementation in cardiovascular disease—what do we know? Nutrients. 7:3094–3118. doi: 10.3390/nu7053094.
   PubMed Web of Science ®Google Scholar
• Conklin DJ, Haberzettl P, Jagatheesan G, Baba S, Merchant ML, Prough RA, Williams JD, Prabhu SD, Bhatnagar A. 2015. Glutathione S-transferase P protects against cyclophosphamide-induced cardiotoxicity in mice. Toxicol Appl Pharmacol. 285:136–148. doi: 10.1016/j.taap.2015.03.029.
   PubMed Web of Science ®Google Scholar
• Danesi F, Malaguti M, Nunzio MD, Maranesi M, Biagi PL, Bordoni A. 2006. Counteraction of adriamycin-induced oxidative damage in rat heart by selenium dietary supplementation. J Agric Food Chem. 54:1203–1208. doi: 10.1021/jf0518002.
   PubMed Web of Science ®Google Scholar
• Daubert MA, Jeremias A. 2010. The utility of troponin measurement to detect myocardial infarction: review of the current findings. Vasc Health Risk Manag. 6:691–699. doi: 10.2147/VHRM.S5306.
   PubMedGoogle Scholar
• Dhesi S, Chu MP, Blevins G, Paterson I, Larratt L, Oudit GY, Kim DH. 2013. Cyclophosphamide-induced cardiomyopathy: a case report, review, and recommendations for management. J Invest Med High Impact Case Rep. 1:2324709613480346. doi: 10.1177/2324709613480346.
   Google Scholar
• Emadi A, Jones RJ, Brodsky RA. 2009. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol. 6:638–647. doi: 10.1038/nrclinonc.2009.146.
   PubMed Web of Science ®Google Scholar
• Firsanov DV, Solovjeva LV, Svetlova MP. 2011. H2AX phosphorylation at the sites of DNA double-strand breaks in cultivated mammalian cells and tissues. Chem Biol Interac. 2:283–297. doi: 10.1007/s13148-011-0044-4.
   Google Scholar
• Gao J, Xiong Y, Ho Y-S, Liu X, Chua CC, Xu X, Wang H, Hamdy R, Chua BH. 2008. Glutathione peroxidase 1-deficient mice are more susceptible to doxorubicin-induced cardiotoxicity. Biochim Biophys Acta Mol Cell Res. 1783:2020–2029. doi: 10.1016/j.bbamcr.2008.05.027.
   Web of Science ®Google Scholar
• Goldberg MA, Antin JH, Guinan EC, Rappeport JM. 1986. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood. 68:1114–1118. doi: 10.1182/blood.V68.5.1114.1114.
   PubMed Web of Science ®Google Scholar
• Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Ziegler J. 1981. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Int Med. 141:758–763. doi: 10.1001/archinte.1981.00340060066015.
   PubMed Web of Science ®Google Scholar
• Gunes S, Sahinturk V, Karasati P, Sahin IK, Ayhanci A. 2017. Cardioprotective effect of selenium against cyclophosphamide-induced cardiotoxicity in rats. Biol Trace Elem Res. 177:107–114. doi: 10.1007/s12011-016-0858-1.
   PubMed Web of Science ®Google Scholar
• Hengstler J, Hengst A, Fuchs J, Tanner B, Pohl J, Oesch F. 1997. Induction of DNA crosslinks and DNA strand lesions by cyclophosphamide after activation by cytochrome P450 2B1. Muta Res Fund Mol Mech Mutagen. 373:215–223. doi: 10.1016/S0027-5107(96)00200-X.
   PubMed Web of Science ®Google Scholar
• Herman EH, Zhang J, Lipshultz SE, Rifai N, Chadwick D, Takeda K, Yu Z-X, Ferrans VJ. 1999. Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol. 17:2237–2243. doi: 10.1200/JCO.1999.17.7.2237.
   PubMed Web of Science ®Google Scholar
• Horacek JM, Pudil R, Tichy M, Jebavy L, Strasova A, Ulrychova M, Zak P, Maly J. 2008. Cardiac troponin I seems to be superior to cardiac troponin T in the early detection of cardiac injury associated with anthracycline treatment. Oncol Res Treat. 31:559–560. doi: 10.1159/000151687.
   Google Scholar
• Iqubal A, Sharma S, Ansari MA, Najmi AK, Syed MA, Ali J, Alam MM, Ahmad S, Haque SE. 2019. Nerolidol attenuates cyclophosphamide-induced cardiac inflammation, apoptosis and fibrosis in Swiss albino mice. Eur J Pharmacol. 863:172666. doi: 10.1016/j.ejphar.2019.172666.
   PubMed Web of Science ®Google Scholar
• Jun E, Ye J, Hwang I, Kim Y, Lee H. 2011. Selenium deficiency contributes to the chronic myocarditis in coxsackievirus-infected mice. Acta Virol. 55:23–29. doi: 10.4149/av_2011_01_23.
   PubMed Web of Science ®Google Scholar
• Kamezaki K, Fukuda T, Makino S, Harada M. 2005. Cyclophosphamide-induced cardiomyopathy in a patient with seminoma and a history of mediastinal irradiation. Int Med. 44:120–123. doi: 10.2169/internalmedicine.44.120.
   PubMed Web of Science ®Google Scholar
• Katayama M, Imai Y, Hashimoto H, Kurata M, Nagai K, Tamita K, Morioka S, Furukawa Y. 2009. Fulminant fatal cardiotoxicity following cyclophosphamide therapy. J Cardiol. 54:330–334. doi: 10.1016/j.jjcc.2009.01.006.
   PubMed Web of Science ®Google Scholar
• Kern JC, Kehrer JP. 2002. Acrolein-induced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis. Chem Biolog Interac. 139:79–95. doi: 10.1016/S0009-2797(01)00295-2.
   PubMed Web of Science ®Google Scholar
• Khanna KK, Jackson SP. 2001. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 27:247–254. doi: 10.1038/85798.
   PubMed Web of Science ®Google Scholar
• Kumar V, Abbas AK, Aster JC. 2020. Robbins and Cotran pathologic basis of disease. 10th ed. Elsevier, Philadelphia, PA. https://www.mea.elsevierhealth.com/robbins-cotran-pathologic-basis-of-disease-9780323531139.html?nosto=nosto-page-search1.
   Google Scholar
• Kuo LJ, Yang L-X. 2008. γ-H2AX-a novel biomarker for DNA double-strand breaks. In vivo. 22:305–309.
   PubMed Web of Science ®Google Scholar
• Kurauchi K, Nishikawa T, Miyahara E, Okamoto Y, Kawano Y. 2017. Role of metabolites of cyclophosphamide in cardiotoxicity. BMC Res Notes. 10:1–10. doi: 10.1186/s13104-017-2726-2.
   PubMedGoogle Scholar
• Li B, Zheng Z, Wei Y, Wang M, Peng J, Kang T, Huang X, Xiao J, Li Y, Li Z. 2011. Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats. Cardiovasc Diabetol. 10:1–8. doi: 10.1186/1475-2840-10-69.
   PubMed Web of Science ®Google Scholar
• Luna LG. 1968. Manual of histologic staining methods of the Armed Forces Institute of Pathology. 3rd ed. McGraw-Hill, New York.
   Google Scholar
• Mansour HH, El Kiki SM, Hasan HF. 2015. Protective effect of N-acetylcysteine on cyclophosphamide-induced cardiotoxicity in rats. Env Toxicol Pharmacol. 40:417–422. doi: 10.1016/j.etap.2015.07.013.
   PubMed Web of Science ®Google Scholar
• Matsuda A, Kimura M, Itokawa Y. 1997. Influence of selenium deficiency on the acute cardiotoxicity of adriamycin in rats. Biol Trace Elem Res. 57:157–167. doi: 10.1007/BF02778199.
   PubMed Web of Science ®Google Scholar
• McDonald GB, Slattery JT, Bouvier ME, Ren S, Batchelder AL, Kalhorn TF, Schoch HG, Anasetti C, Gooley T. 2003. Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood. 101:2043–2048. doi: 10.1182/blood-2002-06-1860.
   PubMed Web of Science ®Google Scholar
• Mojzisová G, Mirossay L, Kucerová D, Kyselovic J, Mirossay A, Mojzis J. 2006. Protective effect of selected flavonoids on in vitro daunorubicin-induced cardiotoxicity. Phytother Res. 20:110–114. doi: 10.1002/ptr.1811.
   PubMed Web of Science ®Google Scholar
• Morandi P, Ruffini P, Benvenuto G, La Vecchia L, Mezzena G, Raimondi R. 2001. Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m2) cyclophosphamide. Bone Marrow Transpl. 28:277–282. doi: 10.1038/sj.bmt.1703132.
   PubMed Web of Science ®Google Scholar
• Morandi P, Ruffini P, Benvenuto G, Raimondi R, Fosser V. 2005. Cardiac toxicity of high-dose chemotherapy. Bone Marrow Transpl. 35:323–334. doi: 10.1038/sj.bmt.1704763.
   PubMed Web of Science ®Google Scholar
• Morawietz G, Ruehl-Fehlert C, Kittel B, Bube A, Keane K, Halm S, Heuser A, Hellmann J. 2004. Revised guides for organ sampling and trimming in rats and mice–part 3. A joint publication of the RITA and NACAD groups. Exp Toxicol Pathol. 55:433–449. doi: 10.1078/0940-2993-00350.
   PubMed Web of Science ®Google Scholar
• Motawi TM, Sadik NA, Refaat A. 2010. Cytoprotective effects of DL-alpha-lipoic acid or squalene on cyclophosphamide-induced oxidative injury: an experimental study on rat myocardium, testicles and urinary bladder. Food Chem Toxicol. 48:2326–2336. doi: 10.1016/j.fct.2010.05.067.
   PubMed Web of Science ®Google Scholar
• Mythili Y, Sudharsan P, Amudha G, Varalakshmi P. 2007. Effect of DL-alpha-lipoic acid on cyclophosphamide induced lysosomal changes in oxidative cardiotoxicity. Life Sci. 80:1993–1998. doi: 10.1016/j.lfs.2007.02.040.
   PubMed Web of Science ®Google Scholar
• Mythili Y, Sudharsan P, Selvakumar E, Varalakshmi P. 2004. Protective effect of DL-alpha-lipoic acid on cyclophosphamide induced oxidative cardiac injury. Chem Biol Interac. 151:13–19. doi: 10.1016/j.cbi.2004.10.004.
   PubMed Web of Science ®Google Scholar
• Omole JG, Ayoka OA, Alabi QK, Adefisayo MA, Asafa MA, Olubunmi BO, Fadeyi BA. 2018. Protective effect of kolaviron on cyclophosphamide-induced cardiac toxicity in rats. J Evid Based Integ Med. 23:2156587218757649. doi: 10.1177/2156587218757649.
   Web of Science ®Google Scholar
• Podhorecka M, Skladanowski A, Bozko P. 2010. H2AX phosphorylation: its role in DNA damage response and cancer therapy. J Nucl Acids. 2010:1–9. doi: 10.4061/2010/920161.
   Google Scholar
• Rao L, White E. 1997. Bcl-2 and the ICE family of apoptotic regulators: making a connection. Curr Opin Genet Dev. 7:52–58. doi: 10.1016/S0959-437X(97)80109-8.
   PubMed Web of Science ®Google Scholar
• Refaie MM, Shehata S, El-Hussieny M, Abdelraheem WM, Bayoumi AM. 2020. Role of ATP-sensitive potassium channel (KATP) and eNOS in mediating the protective effect of nicorandil in cyclophosphamide-induced cardiotoxicity. Cardiovasc Toxicol. 20:71–81. doi: 10.1007/s12012-019-09535-8.
   PubMed Web of Science ®Google Scholar
• Rose AH, Hoffmann PR. 2015. Selenoproteins and cardiovascular stress. Tromb Haemost. 113:494–504. doi: 10.1160/TH14-07-0603.
   PubMed Web of Science ®Google Scholar
• Santos G. 1971. Marrow transplantation in man following cyclophosphamide. Transpl Proc. 3:400–404.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 3:1101–1108. doi: 10.1038/nprot.2008.73.
   PubMed Web of Science ®Google Scholar
• Strok C, Schreffler S. 2014. Cyclophosphamide. Encyclopedia of toxicology. Elsevier, New York. doi: 10.1016/B978-0-12-386454-3.00720-X.
   Google Scholar
• Tanel A, Averill-Bates DA. 2005. The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway. Biochim Biophys Acta Mol Cell Res. 1743:255–267. doi: 10.1016/j.bbamcr.2004.11.007.
   PubMed Web of Science ®Google Scholar
• Tanel A, Averill-Bates DA. 2007. Inhibition of acrolein-induced apoptosis by the antioxidant N-acetylcysteine. J Pharmacol Exp Ther. 321:73–83. doi: 10.1124/jpet.106.114678.
   PubMed Web of Science ®Google Scholar
• Tanguy S, Morel S, Berthonneche C, Toufektsian M-C, De Lorgeril M, Ducros V, Tosaki A, De Leiris J, Boucher F. 2004. Preischemic selenium status as a major determinant of myocardial infarct size in vivo in rats. Antiox Redox Sign. 6:792–796. doi: 10.1089/1523086041361631.
   PubMed Web of Science ®Google Scholar
• Tanguy S, Rakotovao A, Jouan MG, Ghezzi C, de Leiris J, Boucher F. 2011. Dietary selenium intake influences C×43 dephosphorylation, TNF-α expression and cardiac remodeling after reperfused infarction. Mol Nutr Food Res. 55:522–529. doi: 10.1002/mnfr.201000393.
   PubMed Web of Science ®Google Scholar
• Tunca R, Sozmen M, Erdogan H, Citil M, Uzlu E, Ozen H, Gokçe E. 2008. Determination of cardiac troponin I in the blood and heart of calves with foot-and-mouth disease. J Vet Diagn Invest. 20:598–605. doi: 10.1177/104063870802000510.
   PubMed Web of Science ®Google Scholar
• Venardos KM, Perkins A, Headrick J, Kaye DM. 2007. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem. 14:1539–1549. doi: 10.2174/092986707780831078.
   PubMed Web of Science ®Google Scholar
• Xu G, Wang S, Gu B, Yang Y, Song H, Xue W, Liang W, Zhang P. 1997. Further investigation on the role of selenium deficiency in the aetiology and pathogenesis of Keshan disease. Biomed Env Sci. 10:316–326.
   PubMedGoogle Scholar